Mirtazapine for the treatment of interferon-induced psychopathology

General Hospital Psychiatry

Volumn 25, Issue 6, 2003, Pages 497-

  Russo, Sascha ^a   Boon, Jim C ^a   Korf, Jakob ^a   Haagsma, Elizabeth B ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; MIRTAZAPINE; PEGINTERFERON; RECOMBINANT INTERFERON; SEROTONIN UPTAKE INHIBITOR;

DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; HUMAN; IRRITABILITY; LETTER; MENTAL DISEASE; MULTIPLE SCLEROSIS; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PROPHYLAXIS; RATING SCALE; REDUCTION; SEDATION; SEROTONINERGIC SYSTEM; SIDE EFFECT;

EID: 0347594315     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-8343(03)00091-4     Document Type: Letter

References (5)

1. Dieperink E., Willenbring M., Ho S.B. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha a review . Am J Psychiatry. 157:2000;867-876.
2. Menkes D.B., MacDonald J.A. Interferons, serotonin and neurotoxicity. Psychol Med. 30:2000;259-268.
3. Musselman D.L., Lawson D.H., Gumnick J.F., Manatunga A.K., Penna S., Goodkin R.S. Paroxetine for the prevention of depression induced by high-dose interferon alpha. N Engl J Med. 344:2001;961-966.
4. McAllister-Williams R.H., Young A.H., Menkes D.B. Antidepressant response reversed by interferon. Br J Psychiatry. 176:2000;193.
5. Kraus M.R., Schafer A., Scheurlen M. Paroxetine for the prevention of depression induced by interferon alpha. N Engl J Med. 345:2001;375-376.